From 1990 to 2022, the number of new cancer drugs launched annually increased significantly in high-income countries, from 0.5 to over eight per year. However, in upper-middle-income countries, this increase was from 0.1 to 1.5, while lower-income countries saw minimal improvements, highlighting widening global disparities in cancer drug availability. Read The Rest at :
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.
